A Study to Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC Patients

NCT ID: NCT03429673

Last Updated: 2018-05-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

10885 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-12-01

Study Completion Date

2018-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The trial was designed to compare effectiveness and safety of surgeries in the patients with non-small cell lung cancer

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The trial is a multi-centre, real-world, non-interventional, observational study. The Chinese elderly pathologically diagnosed patients with early-stage non-small cell lung cancer enrolled from 2015 to 2017 who received lobectomy or segment/wedge dissection were included and the study data on patient demographic/tumor biological characteristics, and clinical treatments were retrospectively collected to evaluate effectiveness and safety of the surgeries.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-small Cell Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with surgeries

Pathologically diagnosed elderly early Chinese patients with non-small cell lung cancer who received lobectomy or segment/wedge dissection

Surgeries

Intervention Type PROCEDURE

Lobectomy or segment/wedge dissection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Surgeries

Lobectomy or segment/wedge dissection

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who received surgeries from 2014 to 2017;
* Patients who received lobectomy or segment/wedge dissection;
* Pathologically diagnosed patients with non-small cell lung cancer;
* Patients with age \>=65 years old.

Exclusion Criteria

* Patients who received neoadjuvant therapy prior to surgery.
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

LinkDoc Technology (Beijing) Co. Ltd.

INDUSTRY

Sponsor Role collaborator

China-Japan Friendship Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Deruo Liu

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

China-Japan Friendship Hospital

Beijing, Beijing Municipality, China

Site Status

China People's Liberation Army Hospital

Beijing, Beijing Municipality, China

Site Status

Henan Cancer Hospital

Zhengzhou, Henan, China

Site Status

Tongji Hospital Affiliated to Huaxi Technology University

Wuhan, Hubei, China

Site Status

Jiangsu Cancer Hospital

Nanjing, Jiangsu, China

Site Status

Xi'an Tangdu Hospital

Xi'an, Shaanxi, China

Site Status

Shanghai Chest Hospital

Shanghai, Shanghai Municipality, China

Site Status

Huaxi Hospital Affiliate to Sichuan University

Chengdu, Sichuan, China

Site Status

Tianjin Chest Hospital

Tianjin, Tianjin Municipality, China

Site Status

First Hospital Affiliated to Zhejiang University

Hangzhou, Zhejiang, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Zhang Z, Feng H, Zhao H, Hu J, Liu L, Liu Y, Li X, Xu L, Li Y, Lu X, Fu X, Yang H, Liu D. Sublobar resection is associated with better perioperative outcomes in elderly patients with clinical stage I non-small cell lung cancer: a multicenter retrospective cohort study. J Thorac Dis. 2019 May;11(5):1838-1848. doi: 10.21037/jtd.2019.05.20.

Reference Type DERIVED
PMID: 31285876 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CJ-LC-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Perioperative Treatment Outcomes of Early NSCLC
NCT06610240 ENROLLING_BY_INVITATION
Survival Outcomes of Lung Cancer
NCT03647098 RECRUITING